查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1802977

全球經皮菸鹼醯胺市場：2032 年預測 - 按產品形式、分銷管道、應用和地區分析

Transdermal Niacinamide Market Forecasts to 2032 - Global Analysis By Product Form, Distribution Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球經皮菸鹼醯胺市場預計在 2025 年達到 7,087 萬美元，到 2032 年達到 1.1306 億美元，預測期內複合年成長率為 6.9%。

經皮菸鹼醯胺是一種皮膚科和醫學美容解決方案，可透過貼片、凝膠和乳霜等先進劑型將維生素B3直接輸送至皮膚。這種方法可以解決痤瘡、色素沉澱和發炎等特定問題，同時提高生物利用度並繞過口服代謝。人們對非侵入性治療的日益偏好、循證皮膚護膚以及個性化皮膚病學的廣泛趨勢推動了其應用，使其成為醫學美容和皮膚病學實踐中一個充滿希望的領域。

根據Springer的《藥物輸送與轉化研究》（2024），菸鹼醯胺因其美膚、抗衰老和保護皮膚屏障的特性，廣泛應用於局部製劑。非處方產品中的菸鹼醯胺濃度高達20%，其功效與其在NAD+/NADH代謝中的作用有關。

皮膚病增多

隨著皮膚病患病率的上升，消費者尋求有效治療色素沉澱、痤瘡和異位性皮膚炎等疾病，這也推動了經皮菸鹼醯胺劑型的進一步普及。人們日益認知到菸鹼醯胺的皮膚病益處，例如改善皮膚屏障功能和增強保濕效果，這進一步增強了治療和化妝品領域的需求。此外，全球老齡化人口的不斷成長也推動了人們對皮膚病問題的日益關注。此外，近期護膚品輸送系統的創新使得菸鹼醯胺能夠更有效地整合，從而積極促進市場穩定擴張。

先進的經經皮給藥系統高成本

微針貼片、奈米顆粒載體和封裝技術等先進給藥機制的高成本正在阻礙藥物的成長。雖然這些創新提高了生物有效性，但也顯著提高了產品開發和消費者價格，限制了其大規模應用。此外，在高度監管的市場中，製造商面臨著不斷上升的研發和合規成本，進一步限制了其可負擔性。此外，在新興經濟體中，這些藥物通常難以與傳統的口服和外用製劑相比保持成本競爭力。這種價格敏感性可能會限制藥物的使用，並延緩更廣泛的市場滲透。

開發新型交付機制

新型遞送機制的開發正在整合奈米技術、微針和水凝膠系統，以提升皮膚滲透性。先進的封裝技術能夠控制釋放，確保更高的穩定性和功效，促進醫藥與化妝品的合作。此外，兼顧治療和美容需求的多功能產品正在推動創新管道的拓展。隨著消費者對個人化護膚的偏好日益成長，這些進步為實現更好的產品差異化鋪平了道路，加速了菸鹼醯胺的普及，並將其定位為多功能經皮成分。

可能引起皮膚刺激和過敏反應

長期高濃度使用會導致皮膚發紅、接觸性皮膚炎，並破壞敏感肌膚的屏障，進而影響順從性。監管機構強調嚴格的皮膚病學測試，從而延長新配方的上市時間。此外，消費者對刺激性的負面評價可能會損害產品的聲譽，尤其是在化妝品管道。由於安全認知持續顯著影響患者和消費者的接受度，這種風險需要增加對低致敏配方和皮膚病學測試的投資。

COVID-19的影響：

新冠疫情對經皮菸鹼醯胺市場產生了多方面的影響。一方面，原料供應鏈和生產環節的中斷導致分銷面臨短期挑戰，尤其是在新興經濟體。另一方面，由於「口罩痘」疫情以及消費者對居家皮膚護理的重視，消費者對護膚品的需求增加，從而推動了其使用量。此外，電子商務的發展加速了以菸鹼醯胺為基礎的經皮製劑的商店市場。此外，針對皮膚健康和免疫力的臨床研究也強化了菸鹼醯胺作為理想活性成分的地位。

凝膠和乳霜類產品預計將成為預測期內最大的市場

凝膠和乳霜類產品預計將在預測期內佔據最大的市場佔有率，這得益於其使用方便、消費者熟悉度高以及在零售、藥局和線上通路的廣泛分銷。其另一個優點是能夠治療多種皮膚問題，包括痤瘡、瑕疵和皮膚屏障功能障礙。消費者對具有抗衰老和美白功效的藥用化妝品產品的日益偏好也推動了市場的成長。

預計皮膚病診所部門在預測期內將出現最高的複合年成長率。

預計在預測期內，皮膚科診所細分市場將實現最高成長率，這得益於市場對先進個人化護膚療法日益成長的需求。診所是提供皮膚科醫生推薦配方的可靠管道，尤其適用於患有慢性皮膚病和需要專科醫生級別干預的患者。此外，強化的臨床研究檢驗了菸鹼醯胺的有效性和安全性，也增強了其在這些專科門市的採用率。由於患者意識的提高以及對循證治療的重視，預計皮膚科診所仍將是成長最快的通路。

比最大的地區

預計北美將在預測期內佔據最大市場佔有率，這主要得益於其皮膚病的高發病率、消費者對高階護膚品的偏好，以及先進給藥技術的早期採用。美國和加拿大擁有成熟的製藥和化妝品產業，推動產品創新和臨床研究。此外，強大的醫療基礎設施支持皮膚病治療，專利主導的研發也增強了市場競爭力。消費者對美白和抗衰老產品的需求不斷成長，預計將繼續鞏固北美在該地區的主導地位。

複合年成長率最高的地區：

預計亞太地區將在預測期內呈現最高的複合年成長率，這得益於消費者護膚意識的不斷提升、快速的都市化以及可支配收入的不斷成長。中國、日本和韓國等國家正引領護膚創新，將菸鹼醯胺融入治療和化妝品領域。此外，電商平台的擴張和韓妝潮流的興起正在加速年輕一代對菸鹼醯胺的接受度。跨國化妝品公司不斷增加對亞太地區生產設施的投資，從而強化了供應鏈。不斷變化的消費行為和對先進配方的偏好，很可能使該地區成為全球成長最快的地區。

分銷管道

  • 醫院藥房
  • 零售店和便利商店
  • 網上零售/電子商務
  • 皮膚科診所

免費客製化服務

此報告的訂閱者可以從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第 2 章 簡介

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 分析方法
  • 分析材料
    • 主要研究資料
    • 二手研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 市場機會
  • 威脅
  • 應用分析
  • 新興市場
  • COVID-19的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代產品的威脅
  • 新參與企業的威脅
  • 企業之間的競爭

5. 全球經皮菸鹼醯胺市場（依產品形式）

  • 啫咖哩/乳霜
  • 美容精華液
  • 修補
  • 微針貼片

6. 全球經皮菸鹼醯胺市場（依分銷通路）

  • 醫院藥房
  • 零售店和便利商店
  • 網上零售/電子商務
  • 皮膚科診所

7. 全球經皮菸鹼醯胺市場（按應用）

  • 皮膚科
    • 粉刺
    • 酒糟/炎症
    • 牛皮癬和其他皮膚病
  • 美容皮膚科
    • 抗衰老
    • 皮膚亮度和色素沉著
    • 皮膚屏障修復

8. 全球經皮菸鹼醯胺市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第9章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併與收購（M&A）
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章：企業概況

  • DSM-Firmenich
  • BASF
  • Merck KGaA
  • Lonza
  • Bactolac Pharmaceutical
  • Evonik Industries
  • Givaudan
  • Procter & Gamble
  • Unilever
  • L'Oreal
  • Estee Lauder
  • Beiersdorf
  • Johnson & Johnson
  • Amway
  • Shiseido
  • Coty
  • Paula's Choice
  • The Ordinary（Deciem）
  • Galderma
  • Rohto Pharmaceutical
Product Code: SMRC30503

According to Stratistics MRC, the Global Transdermal Niacinamide Market is accounted for $70.87 million in 2025 and is expected to reach $113.06 million by 2032 growing at a CAGR of 6.9% during the forecast period. Transdermal niacinamide is a dermatological and cosmeceutical solution delivering vitamin B3 directly through the skin via advanced formulations such as patches, gels, or creams. This method enhances bioavailability, bypassing oral metabolism while addressing targeted concerns like acne, hyperpigmentation, and inflammation. Its adoption is fueled by rising preference for non-invasive therapies, evidence-based skincare, and the broader trend toward personalized dermatology, making it a promising segment in medical aesthetics and dermatological care.

According to Springer's Drug Delivery and Translational Research (2024), niacinamide is widely used in topical formulations due to its skin-brightening, anti-aging, and barrier-protective properties. Concentrations up to 20% are used in commercial products, and its efficacy is linked to its role in NAD+/NADH metabolism.

Market Dynamics:

Driver:

Growing prevalence of skin disorders

The growing prevalence of skin disorders continues to drive adoption of transdermal niacinamide formulations, as consumers seek effective solutions for conditions such as hyperpigmentation, acne, and atopic dermatitis. Increasing awareness of niacinamide's dermatological benefits, such as improved skin barrier function and enhanced hydration, further strengthens its demand across both therapeutic and cosmetic segments. Additionally, the rise in aging populations globally is fueling adoption due to rising dermatological concerns. Furthermore, recent innovations in skincare delivery systems integrate niacinamide more effectively, positively contributing to steady market expansion.

Restraint:

High cost of advanced transdermal delivery systems

The high cost associated with advanced delivery mechanisms, including microneedle patches, nanoparticle carriers, and encapsulation technologies, is hampering the growth. These innovations, while improving bioavailability, significantly increase product development and consumer pricing, limiting mass adoption. Additionally, manufacturers face higher R&D expenditures and compliance costs in regulated markets, further impacting affordability. Furthermore, lesser-developed economies often struggle with cost competitiveness compared to traditional oral or topical alternatives. This price sensitivity may restrict uptake, thereby slowing broader market penetration.

Opportunity:

Development of novel delivery mechanisms

The development of novel delivery mechanisms integrates nanotechnology, microneedles, and hydrogel systems for improved skin penetration. Advanced encapsulation technologies provide controlled release, ensuring higher stability and efficacy, thereby attracting pharmaceutical and cosmeceutical collaborations. Additionally, multi-functional products catering to both therapeutic and cosmetic needs are stimulating innovation pipelines. With rising consumer preference for personalized skincare, these advancements open avenues for wider product differentiation, accelerating adoption and positioning niacinamide as a versatile transdermal ingredient.

Threat:

Potential skin irritation and allergic reactions

Prolonged use at higher concentrations may trigger redness, contact dermatitis, or barrier disruption in individuals with sensitive skin, thereby limiting compliance. Regulatory bodies emphasize stringent dermatological testing, increasing time-to-market for new formulations. Furthermore, negative consumer reviews regarding irritation can harm product reputation, particularly across cosmetic channels. This risk necessitates greater investment in hypoallergenic formulations and dermatological trials, as safety perceptions will continue to influence patient and consumer acceptance significantly.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the transdermal niacinamide market. On one hand, disruptions in raw material supply chains and manufacturing led to short-term challenges, particularly in distribution across emerging economies. However, rising consumer demand for skincare products due to "maskne" and emphasis on home-based dermatological care boosted usage. Additionally, e-commerce growth accelerated over-the-counter adoption of niacinamide-based transdermal solutions. Furthermore, clinical research on skin health and immunity strengthened niacinamide's profile as a desirable active ingredient.

The gels & creams segment is expected to be the largest during the forecast period

The gels & creams segment is expected to account for the largest market share during the forecast period, driven by their ease of application, consumer familiarity, and widespread distribution through retail, pharmacy, and online channels. Additionally, this segment benefits from versatility in formulations, addressing multiple skin disorders, including acne, dark spots, and barrier dysfunction. The increasing preference for cosmeceutical products with anti-aging and skin-brightening functions also supports market expansion.

The dermatology clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the dermatology clinics segment is predicted to witness the highest growth rate, supported by growing demand for advanced and personalized skincare treatments. Clinics serve as trusted channels for delivering dermatologist-recommended formulations, especially for patients dealing with chronic skin disorders or requiring professional-grade interventions. Furthermore, enhanced clinical research validating niacinamide's efficacy and safety reinforces adoption through these professional outlets. With increasing patient awareness and the rising emphasis on evidence-based therapies, dermatology clinics are expected to remain the fastest-expanding distribution route.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, primarily due to the high prevalence of skin disorders, growing consumer preference for premium skincare products, and early adoption of advanced delivery technologies. Well-established pharmaceutical and cosmetic industries in the U.S. and Canada are driving product innovations and clinical research. Furthermore, strong healthcare infrastructure supports dermatological treatments, and patent-driven R&D enhances market competitiveness. Increasing consumer demand for skin-brightening and anti-aging solutions will continue to strengthen North America's dominant regional position.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rising consumer awareness of skincare, rapid urbanization, and growing disposable incomes. Countries such as China, Japan, and South Korea are leading in skincare innovation, integrating niacinamide across both therapeutic and cosmetic categories. Additionally, expanding e-commerce platforms and K-beauty trends are accelerating adoption across younger demographics. The increased investments by multinational cosmetic firms in Asia-Pacific manufacturing facilities strengthen supply chains. With evolving consumer behavior and preference for advanced formulations, the region is set to deliver the fastest growth trajectory globally.

Key players in the market

Some of the key players in Transdermal Niacinamide Market include DSM-Firmenich, BASF, Merck KGaA, Lonza, Bactolac Pharmaceutical, Evonik Industries, Givaudan, Procter & Gamble, Unilever, L'Oreal, Estee Lauder, Beiersdorf, Johnson & Johnson, Amway, Shiseido, Coty, Paula's Choice, The Ordinary (Deciem), Galderma, and Rohto Pharmaceutical.

Key Developments:

In October 2024, BASF's Personal Care business is launching a new synthetic peptide for skin care applications. Inspired by the natural regenerative process of the skin, Pepsensyal(TM) (INCI: Mannitol (and) Acetyl sh-Tetrapeptide-1 (and) Lauroyl sh-Tetrapeptide-1) has been clinically proven to reduce and delay the first visible signs of aging. The new ingredient is a response to the slow-aging trend, which reflects a shift in consumer attitudes: Rather than fighting the natural aging process, consumers are increasingly concerned with healthy aging through a holistic, preventative approach to skin care.

In October 2024, DSM-Firmenich has developed an upgraded version of their Niacinamide PC product to mark its 10th anniversary. The enhanced formula provides all the traditional benefits with improved efficacy for menopausal skin concerns, addressing dryness, sensitivity, fine lines, and wrinkles by strengthening the skin barrier. Their research shows 27% reduction in transepidermal water loss when 2% niacinamide was applied twice daily for 4 weeks.

In September 2024, Evonik has launched two new products to meet the demands for sustainable, natural actives in the beauty and personal care markets. The two newly launched products are CapilAcid(TM), an active ingredient derived from the Maqui fruit which is a comprehensive protector and powerful antioxidant for the hair, and Oleobiota(TM), an active ingredient sourced sustainably from the Misiones rainforest for sebum-normalizing skin care. Both products originate from the company Novachem, which was acquired by Evonik one year ago and is being integrated into the company's Care Solutions business.

Product Forms Covered:

  • Gels & Creams
  • Serums
  • Patches
  • Microneedle Patches

Distribution Channels:

  • Hospital Pharmacies
  • Retail & Convenience Stores
  • Online Retail/E-commerce
  • Dermatology Clinics

Applications Covered:

  • Medical Dermatology
  • Cosmetic Dermatology

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Transdermal Niacinamide Market, By Product Form

  • 5.1 Introduction
  • 5.2 Gels & Creams
  • 5.3 Serums
  • 5.4 Patches
  • 5.5 Microneedle Patches

6 Global Transdermal Niacinamide Market, By Distribution Channel

  • 6.1 Introduction
  • 6.2 Hospital Pharmacies
  • 6.3 Retail & Convenience Stores
  • 6.4 Online Retail/E-commerce
  • 6.5 Dermatology Clinics

7 Global Transdermal Niacinamide Market, By Application

  • 7.1 Introduction
  • 7.2 Medical Dermatology
    • 7.2.1 Acne
    • 7.2.2 Rosacea & Inflammation
    • 7.2.3 Psoriasis & Other Skin Conditions
  • 7.3 Cosmetic Dermatology
    • 7.3.1 Anti-aging
    • 7.3.2 Skin Brightening & Pigmentation
    • 7.3.3 Skin Barrier Repair

8 Global Transdermal Niacinamide Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 DSM-Firmenich
  • 10.2 BASF
  • 10.3 Merck KGaA
  • 10.4 Lonza
  • 10.5 Bactolac Pharmaceutical
  • 10.6 Evonik Industries
  • 10.7 Givaudan
  • 10.8 Procter & Gamble
  • 10.9 Unilever
  • 10.10 L'Oreal
  • 10.11 Estee Lauder
  • 10.12 Beiersdorf
  • 10.13 Johnson & Johnson
  • 10.14 Amway
  • 10.15 Shiseido
  • 10.16 Coty
  • 10.17 Paula's Choice
  • 10.18 The Ordinary (Deciem)
  • 10.19 Galderma
  • 10.20 Rohto Pharmaceutical

List of Tables

  • Table 1 Global Transdermal Niacinamide Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Transdermal Niacinamide Market Outlook, By Product Form (2024-2032) ($MN)
  • Table 3 Global Transdermal Niacinamide Market Outlook, By Gels & Creams (2024-2032) ($MN)
  • Table 4 Global Transdermal Niacinamide Market Outlook, By Serums (2024-2032) ($MN)
  • Table 5 Global Transdermal Niacinamide Market Outlook, By Patches (2024-2032) ($MN)
  • Table 6 Global Transdermal Niacinamide Market Outlook, By Microneedle Patches (2024-2032) ($MN)
  • Table 7 Global Transdermal Niacinamide Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 8 Global Transdermal Niacinamide Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 9 Global Transdermal Niacinamide Market Outlook, By Retail & Convenience Stores (2024-2032) ($MN)
  • Table 10 Global Transdermal Niacinamide Market Outlook, By Online Retail/E-commerce (2024-2032) ($MN)
  • Table 11 Global Transdermal Niacinamide Market Outlook, By Dermatology Clinics (2024-2032) ($MN)
  • Table 12 Global Transdermal Niacinamide Market Outlook, By Application (2024-2032) ($MN)
  • Table 13 Global Transdermal Niacinamide Market Outlook, By Medical Dermatology (2024-2032) ($MN)
  • Table 14 Global Transdermal Niacinamide Market Outlook, By Acne (2024-2032) ($MN)
  • Table 15 Global Transdermal Niacinamide Market Outlook, By Rosacea & Inflammation (2024-2032) ($MN)
  • Table 16 Global Transdermal Niacinamide Market Outlook, By Psoriasis & Other Skin Conditions (2024-2032) ($MN)
  • Table 17 Global Transdermal Niacinamide Market Outlook, By Cosmetic Dermatology (2024-2032) ($MN)
  • Table 18 Global Transdermal Niacinamide Market Outlook, By Anti-aging (2024-2032) ($MN)
  • Table 19 Global Transdermal Niacinamide Market Outlook, By Skin Brightening & Pigmentation (2024-2032) ($MN)
  • Table 20 Global Transdermal Niacinamide Market Outlook, By Skin Barrier Repair (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.